Vimarsana
Biggest News Aggregation in the World

76115210 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 76115210. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 76115210 Today - Breaking & Trending Today

ResMed Inc. (NYSE:RMD) Shares Bought by Spire Wealth Management - Vimarsana News

ResMed Inc. (NYSE:RMD) Shares Bought by Spire Wealth Management

Spire Wealth Management grew its position in shares of ResMed Inc. (NYSE:RMD – Free Report) by 30,396.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 34,461 shares of the medical equipment provider’s stock after acquiring an additional 34,348 shares during the quarter. […]

Swiss National Bank Sells 12,700 Shares of ResMed Inc. (NYSE:RMD) - Vimarsana News

Swiss National Bank Sells 12,700 Shares of ResMed Inc. (NYSE:RMD)

Swiss National Bank cut its holdings in shares of ResMed Inc. (NYSE:RMD – Free Report) by 2.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 459,900 shares of the medical equipment provider’s stock after selling 12,700 shares during the period. Swiss National Bank owned 0.31% […]

ResMed Inc. (NYSE:RMD) Shares Sold by Norden Group LLC - Vimarsana News

ResMed Inc. (NYSE:RMD) Shares Sold by Norden Group LLC

Norden Group LLC trimmed its holdings in shares of ResMed Inc. (NYSE:RMD – Free Report) by 19.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,400 shares of the medical equipment provider’s stock after selling 336 shares during the period. Norden Group LLC’s holdings in […]

Royal Bank of Canada Increases ResMed (NYSE:RMD) Price Target to $200.00 - Vimarsana News

Royal Bank of Canada Increases ResMed (NYSE:RMD) Price Target to $200.00

ResMed (NYSE:RMD – Free Report) had its price target raised by Royal Bank of Canada from $187.00 to $200.00 in a report issued on Friday, Benzinga reports. The firm currently has a sector perform rating on the medical equipment provider’s stock. A number of other research analysts have also recently commented on the stock. Oppenheimer […]

Source: wkrb13.com
ResMed (NYSE:RMD) Shares Down 3% After Analyst Downgrade - Vimarsana News

ResMed (NYSE:RMD) Shares Down 3% After Analyst Downgrade

ResMed Inc. (NYSE:RMD – Get Free Report) shares fell 3% during trading on Monday after Oppenheimer lowered their price target on the stock from $205.00 to $200.00. Oppenheimer currently has an outperform rating on the stock. ResMed traded as low as $210.20 and last traded at $211.61. 322,132 shares changed hands during mid-day trading, a […]